COMPOSITIONS AND METHODS FOR CRYSTALLIZING ANTIBODIES

The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an industrial scale; a method of controlling the size of antibody crystals, for example, crystals of anti-...

Full description

Saved in:
Bibliographic Details
Main Authors WINTER, GERHARD, GOTTSCHALK, STEFAN, BORHANI, DAVID W, FRAUNHOFER, WOLFGANG
Format Patent
LanguageEnglish
French
Published 12.02.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a batch crystallization method for crystallizing anti-human TNFalpha (hTNFalpha) antibody and antibody fragments which allows the production of said antibody on an industrial scale; a method of controlling the size of antibody crystals, for example, crystals of anti-hTNFalpha antibody fragments, compositions containing said crystals as well as methods of use of said crystals and compositions. La présente invention se rapporte à un procédé de cristallisation discontinu permettant de cristalliser l'anticorps et les fragments d'anticorps antihumain TNFalpha (hTNFalpha). Ce procédé permet la production dudit anticorps à l'échelle industrielle. L'invention concerne également un procédé de contrôle de la taille de cristaux d'anticorps, par exemple, de cristaux de fragments d'anticorps anti-hTNFalpha, les compositions contenant lesdits cristaux ainsi que les procédés d'utilisation des cristaux et des compositions.
Bibliography:Application Number: WO2008US09549